Sofina Société Anonyme(SOF)株式概要ソフィーナ・ソシエテ・アノニムは、直接投資とファンド・オブ・ファンズ投資を専門とするプライベート・エクイティおよびベンチャー・キャピタル会社である。 詳細SOF ファンダメンタル分析スノーフレーク・スコア評価1/6将来の成長0/6過去の実績1/6財務の健全性4/6配当金2/6報酬アナリストらは、株価が31.8%上昇するだろうとほぼ一致している。 リスク分析過去5年間で収益は年間29.9%減少しました。 利益率(58.1%)は昨年より低い(94.9%) すべてのリスクチェックを見るSOF Community Fair Values Create NarrativeSee what 34 others think this stock is worth. Follow their fair value or set your own to get alerts.Top Community NarrativesSofina Société AnonymeSTStoxEuropeCommunity ContributorWhy I invest in Sofina (Dividend growth)NAV As Sofina is an investment holding company, NAV is an important factor in my evaluation. This Net Asset Value is estimated at a price share of 297 Eur, up from 294 last year.View narrative€332.38FV32.7% 割安 内在価値ディスカウント5.00%Revenue growth p.a.Set Fair ValueView159users have viewed this narrative0users have liked this narrative0users have commented on this narrative3users have followed this narrative4 months ago author updated this narrativeTop Community NarrativesSofina Société AnonymeSTStoxEuropeCommunity ContributorWhy I invest in Sofina (Dividend growth)NAV As Sofina is an investment holding company, NAV is an important factor in my evaluation. This Net Asset Value is estimated at a price share of 297 Eur, up from 294 last year.View narrative€332.38FV32.7% 割安 内在価値ディスカウント5.00%Revenue growth p.a.Set Fair ValueView159users have viewed this narrative0users have liked this narrative0users have commented on this narrative3users have followed this narrative4 months ago author updated this narrativeView all narrativesSofina Société Anonyme 競合他社Compagnie du Bois SauvageSymbol: ENXTBR:COMBMarket cap: €501.8mBrederodeSymbol: ENXTBR:BREBMarket cap: €3.0bGimvSymbol: ENXTBR:GIMBMarket cap: €1.8bInfratilSymbol: NZSE:IFTMarket cap: NZ$15.9b価格と性能株価の高値、安値、推移の概要Sofina Société Anonyme過去の株価現在の株価€223.8052週高値€285.2052週安値€203.60ベータ1.171ヶ月の変化0.18%3ヶ月変化-10.48%1年変化-10.19%3年間の変化12.35%5年間の変化-33.59%IPOからの変化1,632.18%最新ニュースDeclared Dividend • May 22Dividend of €2.56 announcedShareholders will receive a dividend of €2.56. Ex-date: 27th May 2026 Payment date: 29th May 2026 Dividend yield will be 1.1%, which is lower than the industry average of 1.6%. Sustainability & Growth Dividend is not covered by earnings (109% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 4.1% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 21% to bring the payout ratio under control. However, EPS has declined by 40% over the last 5 years so the company would need to reverse this trend.お知らせ • May 22Sofina Société Anonyme announces Annual dividend, payable on May 29, 2026Sofina Société Anonyme announced Annual dividend of EUR 2.5620 per share payable on May 29, 2026, ex-date on May 27, 2026 and record date on May 28, 2026.お知らせ • Apr 11Sofina Société Anonyme, Annual General Meeting, May 13, 2026Sofina Société Anonyme, Annual General Meeting, May 13, 2026, at 15:00 Romance Standard Time.New Risk • Mar 29New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 58% Last year net profit margin: 95% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 30% per year over the past 5 years. Minor Risk Profit margins are more than 30% lower than last year (58% net profit margin).お知らせ • Mar 24Sofina Société Anonyme to Report Fiscal Year 2026 Results on Mar 24, 2027Sofina Société Anonyme announced that they will report fiscal year 2026 results on Mar 24, 2027New Risk • Mar 23New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 25% per year over the past 5 years. Minor Risk Latest financial reports are more than 6 months old (reported June 2025 fiscal period end).最新情報をもっと見るRecent updatesDeclared Dividend • May 22Dividend of €2.56 announcedShareholders will receive a dividend of €2.56. Ex-date: 27th May 2026 Payment date: 29th May 2026 Dividend yield will be 1.1%, which is lower than the industry average of 1.6%. Sustainability & Growth Dividend is not covered by earnings (109% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 4.1% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 21% to bring the payout ratio under control. However, EPS has declined by 40% over the last 5 years so the company would need to reverse this trend.お知らせ • May 22Sofina Société Anonyme announces Annual dividend, payable on May 29, 2026Sofina Société Anonyme announced Annual dividend of EUR 2.5620 per share payable on May 29, 2026, ex-date on May 27, 2026 and record date on May 28, 2026.お知らせ • Apr 11Sofina Société Anonyme, Annual General Meeting, May 13, 2026Sofina Société Anonyme, Annual General Meeting, May 13, 2026, at 15:00 Romance Standard Time.New Risk • Mar 29New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 58% Last year net profit margin: 95% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 30% per year over the past 5 years. Minor Risk Profit margins are more than 30% lower than last year (58% net profit margin).お知らせ • Mar 24Sofina Société Anonyme to Report Fiscal Year 2026 Results on Mar 24, 2027Sofina Société Anonyme announced that they will report fiscal year 2026 results on Mar 24, 2027New Risk • Mar 23New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 25% per year over the past 5 years. Minor Risk Latest financial reports are more than 6 months old (reported June 2025 fiscal period end).新しいナラティブ • Feb 04Why I invest in Sofina (Dividend growth)NAV As Sofina is an investment holding company, NAV is an important factor in my evaluation. This Net Asset Value is estimated at a price share of 297 Eur, up from 294 last year.分析記事 • Jan 02Getting In Cheap On Sofina Société Anonyme (EBR:SOF) Is UnlikelyWhen close to half the companies in Belgium have price-to-earnings ratios (or "P/E's") below 15x, you may consider...お知らせ • Oct 30Terumo Corporation (TSE:4543) completed the acquisition of remaining 99.5% stake in OrganOx Limited from a group of shareholders.Terumo Corporation (TSE:4543) has entered into a definitive agreement to acquire remaining 99.5% stake in OrganOx Limited from a group of shareholders for $1.5 billion on August 23, 2025. Upon completion of the transaction, OrganOx will become a wholly owned subsidiary of Terumo. The transaction will be funded from cash on hand and borrowings. For the period ending December 31, 2024, OrganOx Limited reported total revenue of $69.14 million and EBIT of $9.01 million. As of December 31, 2024, OrganOx Limited reported total assets of $96.9 million and total common equity of $71.56 million. The transaction is subject to approval by regulatory board / committee. The transaction is expected to close in FY2025. Perella Weinberg Partners and Piper Sandler served as OrganOx’s financial advisors and Robbie McLaren, Ross McAloon, Charles Ruck, Elizabeth Richards, Betty Pang, Chad Jennings, Sean Finn, Maj Vaseghi, Kendall Burnett, Hector Armengod, Patrick English, Catherine Hein and Philipp Studt of Latham & Watkins acted as legal counsel to OrganOx in this transaction. Terumo Corporation (TSE:4543) completed the acquisition of remaining 99.5% stake in OrganOx Limited from a group of shareholders on October 29, 2025.分析記事 • Sep 07Some Shareholders Feeling Restless Over Sofina Société Anonyme's (EBR:SOF) P/E RatioSofina Société Anonyme's ( EBR:SOF ) price-to-earnings (or "P/E") ratio of 20.2x might make it look like a sell right...お知らせ • Sep 04Sofina Société Anonyme to Report First Half, 2026 Results on Sep 03, 2026Sofina Société Anonyme announced that they will report first half, 2026 results on Sep 03, 2026お知らせ • Aug 25Terumo Corporation (TSE:4543) has entered into a definitive agreement to acquire 99.5% stake in OrganOx Limited from a group of shareholders in a transaction valued at $1.5 billion.Terumo Corporation (TSE:4543) has entered into a definitive agreement to acquire 99.5% stake in OrganOx Limited from a group of shareholders in a transaction valued at $1.5 billion on August 23, 2025. Upon completion of the transaction, OrganOx will become a wholly owned subsidiary of Terumo. For the period ending December 31, 2024, OrganOx Limited reported total revenue of $69.14 million and EBIT of $9.01 million. As of December 31, 2024, OrganOx Limited reported total assets of $96.9 million and total common equity of $71.56 million. The transaction is subject to approval by regulatory board / committee. Perella Weinberg Partners and Piper Sandler served as OrganOx’s financial advisors and Latham & Watkins acted as legal counsel to OrganOx in this transaction.Upcoming Dividend • May 13Upcoming dividend of €2.45 per shareEligible shareholders must have bought the stock before 20 May 2025. Payment date: 22 May 2025. Payout ratio is a comfortable 8.6% but the company is paying out more than the cash it is generating. Trailing yield: 1.4%. Lower than top quartile of Belgian dividend payers (6.7%). Lower than average of industry peers (2.8%).お知らせ • Apr 25Proeduca Summa, S.L., Renta Genova, S.L., Asua Inversiones, S.L., Portobello Capital Gestión, SGEIC, S.A. and Sofina Société Anonyme (ENXTBR:SOF) proposed to acquire 7.09% stake in Proeduca Altus, S.A. (BME:PRO) for approximately €110 million.Proeduca Summa, S.L., Renta Genova, S.L., Asua Inversiones, S.L., Portobello Capital Gestión, SGEIC, S.A. and Sofina Société Anonyme (ENXTBR:SOF) proposed to acquire 7.09% stake in Proeduca Altus, S.A. (BME:PRO) for approximately €110 million on April 24, 2025. A cash consideration valued at €34.01 per share will be paid by Proeduca Summa, S.L., Renta Genova, S.L., Asua Inversiones, S.L., Portobello Capital Gestión, SGEIC, S.A. and Sofina Société Anonyme. As part of consideration, an undisclosed value is paid towards common equity of Proeduca Altus, S.A. The proposed price for the offer is €34.01 per share, valuing the Proeduca Altus at approximately €1.536 billion. The transaction is subject to Proeduca Altus shareholders approval. Ernst & Young Transaction Advisory Services España acted as fairness opinion provider to Proeduca Altus, S.A.お知らせ • Mar 27Sofina Société Anonyme to Report Fiscal Year 2025 Final Results on Mar 26, 2026Sofina Société Anonyme announced that they will report fiscal year 2025 final results on Mar 26, 2026New Risk • Mar 24New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 35% per year over the past 5 years. Minor Risk Latest financial reports are more than 6 months old (reported June 2024 fiscal period end).Price Target Changed • Jul 11Price target decreased by 14% to €292Down from €341, the current price target is an average from 3 analysts. New target price is 36% above last closing price of €214. Stock is up 9.3% over the past year. The company posted a net loss per share of €3.12 last year.お知らせ • Apr 04Sofina Société Anonyme, Annual General Meeting, May 08, 2025Sofina Société Anonyme, Annual General Meeting, May 08, 2025.お知らせ • Mar 29Sofina Société Anonyme to Report Fiscal Year 2024 Results on Mar 26, 2025Sofina Société Anonyme announced that they will report fiscal year 2024 results on Mar 26, 2025New Risk • Mar 24New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 22% per year over the past 5 years. Revenue is less than US$1m. Minor Risk Latest financial reports are more than 6 months old (reported June 2023 fiscal period end).お知らせ • Jan 23Sofina Société Anonyme to Report First Half, 2024 Results on Sep 05, 2024Sofina Société Anonyme announced that they will report first half, 2024 results on Sep 05, 2024お知らせ • Dec 20Proofpoint, Inc. acquire Tessian Limited.Proofpoint, Inc. entered into a definitive agreement to acquire Tessian Limited on October 30, 2023. Tessian’s solutions are expected to become part of Proofpoint’s offering upon the closing of the acquisition. The acquisition is expected to close in late 2023 to early 2024, subject to customary closing conditions, including any required regulatory approvals. Piper Sandler Ltd. acted as financial advisor to Tessian Limited. Vincent Bergin, Peter Stach, P.C., Andrew Struckmeyer, David Higgins, Corey D. Fox, P.C., Bradley C. Reed, P.C., John Patten, Peter Abbott, Matthew Sinclair-Thomson, Kirsteen Nicol, Katherine C. Nemeth, Michael Falk, P.C., Sydney Jones and Jackson Phinney of Kirkland & Ellis International LLP and Kirkland & Ellis LLP acted as legal advisor to Proofpoint. The transaction is closed on December 19, 2023.Proofpoint, Inc. completed the acquisition of Tessian Limited on December 19, 2023.Upcoming Dividend • May 05Upcoming dividend of €2.27 per share at 1.6% yieldEligible shareholders must have bought the stock before 12 May 2023. Payment date: 16 May 2023. The company is not currently making a profit but it is cash flow positive. Trailing yield: 1.6%. Lower than top quartile of Belgian dividend payers (6.4%). Lower than average of industry peers (2.6%).Price Target Changed • Nov 16Price target decreased to €367Down from €415, the current price target is an average from 2 analysts. New target price is 66% above last closing price of €221. Stock is down 45% over the past year. The company posted earnings per share of €76.99 last year.Price Target Changed • Jun 01Price target decreased to €367Down from €420, the current price target is provided by 1 analyst. New target price is 69% above last closing price of €217. Stock is down 37% over the past year. The company posted earnings per share of €76.99 last year.Valuation Update With 7 Day Price Move • May 24Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to €234, the stock trades at a trailing P/E ratio of 3x. Average trailing P/E is 9x in the Diversified Financial industry in Europe. Total returns to shareholders of 35% over the past three years.Upcoming Dividend • May 06Upcoming dividend of €2.19 per shareEligible shareholders must have bought the stock before 13 May 2022. Payment date: 17 May 2022. Payout ratio is a comfortable 4.1% but the company is not cash flow positive. Trailing yield: 1.1%. Lower than top quartile of Belgian dividend payers (5.7%). Lower than average of industry peers (2.6%).Price Target Changed • Jul 24Price target increased to €348Up from €310, the current price target is provided by 1 analyst. New target price is 12% below last closing price of €396. Stock is up 70% over the past year.Price Target Changed • Mar 22Price target increased to €310Up from €283, the current price target is provided by 1 analyst. New target price is 6.7% above last closing price of €291. Stock is up 74% over the past year.Is New 90 Day High Low • Feb 03New 90-day high: €286The company is up 22% from its price of €235 on 04 November 2020. The Belgian market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Diversified Financial industry, which is up 17% over the same period.Is New 90 Day High Low • Dec 29New 90-day high: €275The company is up 18% from its price of €233 on 30 September 2020. The Belgian market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Diversified Financial industry, which is up 12% over the same period.Is New 90 Day High Low • Nov 17New 90-day high: €260The company is up 7.0% from its price of €243 on 19 August 2020. The Belgian market is up 10.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Diversified Financial industry, which is up 5.0% over the same period.Is New 90 Day High Low • Oct 29New 90-day low: €223The company is down 4.0% from its price of €234 on 30 July 2020. The Belgian market is down 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Diversified Financial industry, which is down 6.0% over the same period.株主還元SOFBE Diversified FinancialBE 市場7D2.8%3.6%2.0%1Y-10.2%2.1%22.6%株主還元を見る業界別リターン: SOF過去 1 年間で2.1 % の収益を上げたBelgian Diversified Financial業界を下回りました。リターン対市場: SOFは、過去 1 年間で22.6 % のリターンを上げたBelgian市場を下回りました。価格変動Is SOF's price volatile compared to industry and market?SOF volatilitySOF Average Weekly Movement3.7%Diversified Financial Industry Average Movement3.7%Market Average Movement4.4%10% most volatile stocks in BE Market7.1%10% least volatile stocks in BE Market2.7%安定した株価: SOF 、 Belgian市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: SOFの 週次ボラティリティ ( 4% ) は過去 1 年間安定しています。会社概要設立従業員CEO(最高経営責任者ウェブサイト189883Harold Y. Boelwww.sofinagroup.comソフィーナ・ソシエテ・アノニムは、直接投資とファンド・オブ・ファンズ投資を専門とするプライベート・エクイティおよびベンチャー・キャピタル会社である。直接投資では、グロース・キャピタル、初期投資、スタートアップ投資、後期投資、成熟投資、新興成長投資、中期投資、後期投資、LBO投資を専門としている。主に、デジタル・トランスフォーメーション、消費財・小売、教育、ヘルスケア、ライフサイエンス、持続可能なサプライチェーン、エネルギー、サービス、eコマース、消費財、デジタル、衛星事業、産業、金融会社、金融サービスに携わる世界中の企業のポートフォリオに投資している。また、メディア、通信、保険、不動産開発セクターにも投資している。通常、欧州を拠点とし、グローバルなエクスポージャーを持つ企業に投資し、特に西ヨーロッパとインド、中国、東南アジア、米国などのアジアを拠点とする企業に重点を置いている。1億ユーロ(1億308万ドル)から3億ユーロ(3億925万ドル)のマイノリティ投資を行う。2000万ユーロ(2062万ドル)から1億ユーロ(1億308万ドル)の間で、急成長中の事業への投資を目指す。500万ユーロ(535万ドル)から5,000万ユーロ(5,418万ドル)の間で、ベンチャー・キャピタルやグロース・キャピタル・ファンドへの出資を募っている。非上場企業および上場企業に投資。非上場企業に対しては、成長支援、買収資金調達、既存株主・家族への流動性提供、売却プロセス支援、支配株主と並ぶ少数株主への投資、上場企業に対しては、既存株主の代替わり、支配株主の長期的支援、上場廃止のための投資を行う。ファンド・オブ・ファンズでは、プライベート・エクイティ、ベンチャー・キャピタル、グロース・エクイティ・ファンドを中心に、バイアウトやスペシャル・シチュエーションのファンドも扱っている。また、プライベート・エクイティ・ファンドの各分野のファンドも運用している。通常、北米、米国、欧州、アジアに投資し、新興市場にも注力している。同社は、投資先企業の少数株主持分を保有することを好み、取締役会の議席を求める。マジョリティ出資や共同投資も好む。投資期間は通常10年から12年。ソフィーナ・ソシエテ・アノニムは1898年に設立され、ベルギーのブリュッセルに本社を置き、ルクセンブルク、シンガポール、英国ロンドンにオフィスを構えている。もっと見るSofina Société Anonyme 基礎のまとめSofina Société Anonyme の収益と売上を時価総額と比較するとどうか。SOF 基礎統計学時価総額€7.94b収益(TTM)€113.00m売上高(TTM)€194.37m70.2xPER(株価収益率40.8xP/SレシオSOF は割高か?公正価値と評価分析を参照収益と収入最新の決算報告書(TTM)に基づく主な収益性統計SOF 損益計算書(TTM)収益€194.37m売上原価€0売上総利益€194.37mその他の費用€81.37m収益€113.00m直近の収益報告Dec 31, 2025次回決算日Sep 02, 2026一株当たり利益(EPS)3.19グロス・マージン100.00%純利益率58.14%有利子負債/自己資本比率11.9%SOF の長期的なパフォーマンスは?過去の実績と比較を見る配当金1.6%現在の配当利回り109%配当性向SOF 配当は確実ですか?SOF 配当履歴とベンチマークを見るSOF 、いつまでに購入すれば配当金を受け取れますか?Sofina Société Anonyme 配当日配当落ち日May 27 2026配当支払日May 29 2026配当落ちまでの日数3 days配当支払日までの日数5 daysSOF 配当は確実ですか?SOF 配当履歴とベンチマークを見るView Valuation企業分析と財務データの現状データ最終更新日(UTC時間)企業分析2026/05/22 00:30終値2026/05/22 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Sofina Société Anonyme 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Marc DebrouwerDegroof Petercam
Declared Dividend • May 22Dividend of €2.56 announcedShareholders will receive a dividend of €2.56. Ex-date: 27th May 2026 Payment date: 29th May 2026 Dividend yield will be 1.1%, which is lower than the industry average of 1.6%. Sustainability & Growth Dividend is not covered by earnings (109% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 4.1% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 21% to bring the payout ratio under control. However, EPS has declined by 40% over the last 5 years so the company would need to reverse this trend.
お知らせ • May 22Sofina Société Anonyme announces Annual dividend, payable on May 29, 2026Sofina Société Anonyme announced Annual dividend of EUR 2.5620 per share payable on May 29, 2026, ex-date on May 27, 2026 and record date on May 28, 2026.
お知らせ • Apr 11Sofina Société Anonyme, Annual General Meeting, May 13, 2026Sofina Société Anonyme, Annual General Meeting, May 13, 2026, at 15:00 Romance Standard Time.
New Risk • Mar 29New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 58% Last year net profit margin: 95% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 30% per year over the past 5 years. Minor Risk Profit margins are more than 30% lower than last year (58% net profit margin).
お知らせ • Mar 24Sofina Société Anonyme to Report Fiscal Year 2026 Results on Mar 24, 2027Sofina Société Anonyme announced that they will report fiscal year 2026 results on Mar 24, 2027
New Risk • Mar 23New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 25% per year over the past 5 years. Minor Risk Latest financial reports are more than 6 months old (reported June 2025 fiscal period end).
Declared Dividend • May 22Dividend of €2.56 announcedShareholders will receive a dividend of €2.56. Ex-date: 27th May 2026 Payment date: 29th May 2026 Dividend yield will be 1.1%, which is lower than the industry average of 1.6%. Sustainability & Growth Dividend is not covered by earnings (109% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 4.1% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 21% to bring the payout ratio under control. However, EPS has declined by 40% over the last 5 years so the company would need to reverse this trend.
お知らせ • May 22Sofina Société Anonyme announces Annual dividend, payable on May 29, 2026Sofina Société Anonyme announced Annual dividend of EUR 2.5620 per share payable on May 29, 2026, ex-date on May 27, 2026 and record date on May 28, 2026.
お知らせ • Apr 11Sofina Société Anonyme, Annual General Meeting, May 13, 2026Sofina Société Anonyme, Annual General Meeting, May 13, 2026, at 15:00 Romance Standard Time.
New Risk • Mar 29New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 58% Last year net profit margin: 95% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 30% per year over the past 5 years. Minor Risk Profit margins are more than 30% lower than last year (58% net profit margin).
お知らせ • Mar 24Sofina Société Anonyme to Report Fiscal Year 2026 Results on Mar 24, 2027Sofina Société Anonyme announced that they will report fiscal year 2026 results on Mar 24, 2027
New Risk • Mar 23New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 25% per year over the past 5 years. Minor Risk Latest financial reports are more than 6 months old (reported June 2025 fiscal period end).
新しいナラティブ • Feb 04Why I invest in Sofina (Dividend growth)NAV As Sofina is an investment holding company, NAV is an important factor in my evaluation. This Net Asset Value is estimated at a price share of 297 Eur, up from 294 last year.
分析記事 • Jan 02Getting In Cheap On Sofina Société Anonyme (EBR:SOF) Is UnlikelyWhen close to half the companies in Belgium have price-to-earnings ratios (or "P/E's") below 15x, you may consider...
お知らせ • Oct 30Terumo Corporation (TSE:4543) completed the acquisition of remaining 99.5% stake in OrganOx Limited from a group of shareholders.Terumo Corporation (TSE:4543) has entered into a definitive agreement to acquire remaining 99.5% stake in OrganOx Limited from a group of shareholders for $1.5 billion on August 23, 2025. Upon completion of the transaction, OrganOx will become a wholly owned subsidiary of Terumo. The transaction will be funded from cash on hand and borrowings. For the period ending December 31, 2024, OrganOx Limited reported total revenue of $69.14 million and EBIT of $9.01 million. As of December 31, 2024, OrganOx Limited reported total assets of $96.9 million and total common equity of $71.56 million. The transaction is subject to approval by regulatory board / committee. The transaction is expected to close in FY2025. Perella Weinberg Partners and Piper Sandler served as OrganOx’s financial advisors and Robbie McLaren, Ross McAloon, Charles Ruck, Elizabeth Richards, Betty Pang, Chad Jennings, Sean Finn, Maj Vaseghi, Kendall Burnett, Hector Armengod, Patrick English, Catherine Hein and Philipp Studt of Latham & Watkins acted as legal counsel to OrganOx in this transaction. Terumo Corporation (TSE:4543) completed the acquisition of remaining 99.5% stake in OrganOx Limited from a group of shareholders on October 29, 2025.
分析記事 • Sep 07Some Shareholders Feeling Restless Over Sofina Société Anonyme's (EBR:SOF) P/E RatioSofina Société Anonyme's ( EBR:SOF ) price-to-earnings (or "P/E") ratio of 20.2x might make it look like a sell right...
お知らせ • Sep 04Sofina Société Anonyme to Report First Half, 2026 Results on Sep 03, 2026Sofina Société Anonyme announced that they will report first half, 2026 results on Sep 03, 2026
お知らせ • Aug 25Terumo Corporation (TSE:4543) has entered into a definitive agreement to acquire 99.5% stake in OrganOx Limited from a group of shareholders in a transaction valued at $1.5 billion.Terumo Corporation (TSE:4543) has entered into a definitive agreement to acquire 99.5% stake in OrganOx Limited from a group of shareholders in a transaction valued at $1.5 billion on August 23, 2025. Upon completion of the transaction, OrganOx will become a wholly owned subsidiary of Terumo. For the period ending December 31, 2024, OrganOx Limited reported total revenue of $69.14 million and EBIT of $9.01 million. As of December 31, 2024, OrganOx Limited reported total assets of $96.9 million and total common equity of $71.56 million. The transaction is subject to approval by regulatory board / committee. Perella Weinberg Partners and Piper Sandler served as OrganOx’s financial advisors and Latham & Watkins acted as legal counsel to OrganOx in this transaction.
Upcoming Dividend • May 13Upcoming dividend of €2.45 per shareEligible shareholders must have bought the stock before 20 May 2025. Payment date: 22 May 2025. Payout ratio is a comfortable 8.6% but the company is paying out more than the cash it is generating. Trailing yield: 1.4%. Lower than top quartile of Belgian dividend payers (6.7%). Lower than average of industry peers (2.8%).
お知らせ • Apr 25Proeduca Summa, S.L., Renta Genova, S.L., Asua Inversiones, S.L., Portobello Capital Gestión, SGEIC, S.A. and Sofina Société Anonyme (ENXTBR:SOF) proposed to acquire 7.09% stake in Proeduca Altus, S.A. (BME:PRO) for approximately €110 million.Proeduca Summa, S.L., Renta Genova, S.L., Asua Inversiones, S.L., Portobello Capital Gestión, SGEIC, S.A. and Sofina Société Anonyme (ENXTBR:SOF) proposed to acquire 7.09% stake in Proeduca Altus, S.A. (BME:PRO) for approximately €110 million on April 24, 2025. A cash consideration valued at €34.01 per share will be paid by Proeduca Summa, S.L., Renta Genova, S.L., Asua Inversiones, S.L., Portobello Capital Gestión, SGEIC, S.A. and Sofina Société Anonyme. As part of consideration, an undisclosed value is paid towards common equity of Proeduca Altus, S.A. The proposed price for the offer is €34.01 per share, valuing the Proeduca Altus at approximately €1.536 billion. The transaction is subject to Proeduca Altus shareholders approval. Ernst & Young Transaction Advisory Services España acted as fairness opinion provider to Proeduca Altus, S.A.
お知らせ • Mar 27Sofina Société Anonyme to Report Fiscal Year 2025 Final Results on Mar 26, 2026Sofina Société Anonyme announced that they will report fiscal year 2025 final results on Mar 26, 2026
New Risk • Mar 24New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 35% per year over the past 5 years. Minor Risk Latest financial reports are more than 6 months old (reported June 2024 fiscal period end).
Price Target Changed • Jul 11Price target decreased by 14% to €292Down from €341, the current price target is an average from 3 analysts. New target price is 36% above last closing price of €214. Stock is up 9.3% over the past year. The company posted a net loss per share of €3.12 last year.
お知らせ • Apr 04Sofina Société Anonyme, Annual General Meeting, May 08, 2025Sofina Société Anonyme, Annual General Meeting, May 08, 2025.
お知らせ • Mar 29Sofina Société Anonyme to Report Fiscal Year 2024 Results on Mar 26, 2025Sofina Société Anonyme announced that they will report fiscal year 2024 results on Mar 26, 2025
New Risk • Mar 24New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 22% per year over the past 5 years. Revenue is less than US$1m. Minor Risk Latest financial reports are more than 6 months old (reported June 2023 fiscal period end).
お知らせ • Jan 23Sofina Société Anonyme to Report First Half, 2024 Results on Sep 05, 2024Sofina Société Anonyme announced that they will report first half, 2024 results on Sep 05, 2024
お知らせ • Dec 20Proofpoint, Inc. acquire Tessian Limited.Proofpoint, Inc. entered into a definitive agreement to acquire Tessian Limited on October 30, 2023. Tessian’s solutions are expected to become part of Proofpoint’s offering upon the closing of the acquisition. The acquisition is expected to close in late 2023 to early 2024, subject to customary closing conditions, including any required regulatory approvals. Piper Sandler Ltd. acted as financial advisor to Tessian Limited. Vincent Bergin, Peter Stach, P.C., Andrew Struckmeyer, David Higgins, Corey D. Fox, P.C., Bradley C. Reed, P.C., John Patten, Peter Abbott, Matthew Sinclair-Thomson, Kirsteen Nicol, Katherine C. Nemeth, Michael Falk, P.C., Sydney Jones and Jackson Phinney of Kirkland & Ellis International LLP and Kirkland & Ellis LLP acted as legal advisor to Proofpoint. The transaction is closed on December 19, 2023.Proofpoint, Inc. completed the acquisition of Tessian Limited on December 19, 2023.
Upcoming Dividend • May 05Upcoming dividend of €2.27 per share at 1.6% yieldEligible shareholders must have bought the stock before 12 May 2023. Payment date: 16 May 2023. The company is not currently making a profit but it is cash flow positive. Trailing yield: 1.6%. Lower than top quartile of Belgian dividend payers (6.4%). Lower than average of industry peers (2.6%).
Price Target Changed • Nov 16Price target decreased to €367Down from €415, the current price target is an average from 2 analysts. New target price is 66% above last closing price of €221. Stock is down 45% over the past year. The company posted earnings per share of €76.99 last year.
Price Target Changed • Jun 01Price target decreased to €367Down from €420, the current price target is provided by 1 analyst. New target price is 69% above last closing price of €217. Stock is down 37% over the past year. The company posted earnings per share of €76.99 last year.
Valuation Update With 7 Day Price Move • May 24Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to €234, the stock trades at a trailing P/E ratio of 3x. Average trailing P/E is 9x in the Diversified Financial industry in Europe. Total returns to shareholders of 35% over the past three years.
Upcoming Dividend • May 06Upcoming dividend of €2.19 per shareEligible shareholders must have bought the stock before 13 May 2022. Payment date: 17 May 2022. Payout ratio is a comfortable 4.1% but the company is not cash flow positive. Trailing yield: 1.1%. Lower than top quartile of Belgian dividend payers (5.7%). Lower than average of industry peers (2.6%).
Price Target Changed • Jul 24Price target increased to €348Up from €310, the current price target is provided by 1 analyst. New target price is 12% below last closing price of €396. Stock is up 70% over the past year.
Price Target Changed • Mar 22Price target increased to €310Up from €283, the current price target is provided by 1 analyst. New target price is 6.7% above last closing price of €291. Stock is up 74% over the past year.
Is New 90 Day High Low • Feb 03New 90-day high: €286The company is up 22% from its price of €235 on 04 November 2020. The Belgian market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Diversified Financial industry, which is up 17% over the same period.
Is New 90 Day High Low • Dec 29New 90-day high: €275The company is up 18% from its price of €233 on 30 September 2020. The Belgian market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Diversified Financial industry, which is up 12% over the same period.
Is New 90 Day High Low • Nov 17New 90-day high: €260The company is up 7.0% from its price of €243 on 19 August 2020. The Belgian market is up 10.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Diversified Financial industry, which is up 5.0% over the same period.
Is New 90 Day High Low • Oct 29New 90-day low: €223The company is down 4.0% from its price of €234 on 30 July 2020. The Belgian market is down 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Diversified Financial industry, which is down 6.0% over the same period.